$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
奥拉帕尼改善乳腺癌患者生存期
2025-10-19 11:44:20
Check Details
拉帕替尼联合卡培他滨治疗乳腺癌
2025-10-19 11:44:20
Check Details
奥拉帕利治疗转移性乳腺癌
2025-10-19 11:44:20
Check Details
帕博西尼联合来曲唑治疗乳腺癌
2025-10-19 11:44:20
Check Details
吉西他滨与紫杉醇联合治疗乳腺癌
2025-10-19 11:44:20
Check Details
帕博西林联合来曲唑治疗乳腺癌的优势
2025-10-19 11:44:20
Check Details
舒尼替尼联合多西紫杉醇治疗晚期乳腺癌
2025-10-19 11:44:20
Check Details
帕博西林显著提高乳腺癌患者治疗率
2025-10-19 11:44:20
Check Details
卡培他滨可用于晚期乳腺癌维持治疗
2025-10-19 11:44:20
Check Details
帕博西林与内分泌疗法联合可对抗多种癌症
2025-10-19 11:44:20
Check Details
奥拉帕尼使BRCA突变的乳腺癌患者获益
2025-10-19 11:44:20
Check Details
依维莫司联合来曲唑治疗HER2阴性乳腺癌
2025-10-19 11:44:20
Check Details
1
2
...
1647
1648
1649
1650
1651
1652
1653
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
2
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
3
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
4
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
5
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
6
Adagrasib Medication Management Guide for Special Populations
7
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
8
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
9
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
10
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
11
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
12
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer